Oscar Health, Inc. $OSCR Stock Holdings Lifted by Park West Asset Management LLC

Key Points

Error: Response status code does not indicate success: 502 (Bad Gateway).

Park West Asset Management LLC increased its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 36.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,263,973 shares of the company's stock after purchasing an additional 338,973 shares during the period. Park West Asset Management LLC owned 0.50% of Oscar Health worth $16,571,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Hsbc Holdings PLC increased its position in Oscar Health by 2.7% in the first quarter. Hsbc Holdings PLC now owns 24,113 shares of the company's stock worth $313,000 after buying an additional 632 shares during the period. Tempus Wealth Planning LLC grew its position in shares of Oscar Health by 6.7% during the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock worth $189,000 after acquiring an additional 906 shares during the last quarter. Xponance Inc. grew its position in shares of Oscar Health by 7.1% during the first quarter. Xponance Inc. now owns 15,423 shares of the company's stock worth $202,000 after acquiring an additional 1,029 shares during the last quarter. CWM LLC increased its holdings in shares of Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after acquiring an additional 1,078 shares during the period. Finally, Corebridge Financial Inc. lifted its position in Oscar Health by 1.1% in the 1st quarter. Corebridge Financial Inc. now owns 100,119 shares of the company's stock valued at $1,313,000 after purchasing an additional 1,087 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Price Performance

Shares of Oscar Health stock traded down $0.24 during trading on Tuesday, hitting $20.04. The stock had a trading volume of 17,435,575 shares, compared to its average volume of 16,595,408. The business has a fifty day moving average of $15.75 and a two-hundred day moving average of $15.07. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The firm has a market cap of $5.18 billion, a P/E ratio of -24.74 and a beta of 1.87. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same period in the previous year, the company earned $0.20 earnings per share. Oscar Health's revenue was up 29.0% compared to the same quarter last year. On average, sell-side analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Piper Sandler decreased their target price on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. Wall Street Zen lowered Oscar Health from a "hold" rating to a "sell" rating in a report on Saturday, August 9th. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Barclays reduced their price target on Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research report on Wednesday, July 23rd. Finally, Robert W. Baird reissued a "neutral" rating and set a $14.00 price target (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Four analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Strong Sell" and an average price target of $12.07.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.